Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xinrong Xiang

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Entropy (Basel, Switzerland)|February 25, 2023
Change-Point Detection in a High-Dimensional Multinomial Sequence Based on Mutual InformationXinrong Xiang, Baisuo Jin, Yuehua Wu
BMC Genetics|November 25, 2020
Identifying rare variants for quantitative traits in extreme samples of population via Kullback-Leibler distanceYang Xiang, Xinrong Xiang, Yumei Li
British Journal of Pharmacology|March 30, 2022
Targeting mitochondrial proteases for therapy of acute myeloid leukaemiaXinrong Xiang, Rui Bao, Yu Wu, et al.
Cytokine|September 8, 2019
Relationship between the IL-10 (-1082 A/G) polymorphism and the risk of immune/idiopathic thrombocytopenic purpura: A meta-analysisYang Ou, Yan Yang, Xinrong Xiang, et al.
Pharmacological Research|April 1, 2022
Epigenetic changes in Mycobacterium tuberculosis and its host provide potential targets or biomarkers for drug discovery and clinical diagnosisJing Sui, Wenliang Qiao, Xinrong Xiang, et al.
Frontiers in Pharmacology|December 21, 2020
Efficacy and Safety of CAR-Modified T Cell Therapy in Patients with Relapsed or Refractory Multiple Myeloma: A Meta-Analysis of Prospective Clinical TrialsXinrong Xiang, Qiao He, Yang Ou, et al.
Cytokine|January 12, 2025
The diagnostic value and clinical correlations of bone marrow supernatant S100A8 and S100A9 in myelodysplastic neoplasmsXuefeng Li, Qing Li, Xinrong Xiang, et al.
Biomolecules|June 26, 2025
Myelodysplastic Neoplasms (MDS): Pathogenesis and Therapeutic ProspectsXuefeng Li, Chaoyu Zou, Xinrong Xiang, et al.
British Journal of Haematology|September 28, 2022
Differentiation therapy using low-dose venetoclax in a variant acute promyelocytic leukaemia carrying ZBTB16-RARAHe Li, Xinrong Xiang, Hong Ding, et al.
Journal of Medicinal Chemistry|June 21, 2024
Discovery of 5-(Piperidin-4-yl)-1,2,4-oxadiazole Derivatives as a New Class of Human Caseinolytic Protease P Agonists for the Treatment of Hepatocellular CarcinomaSong Liu, Jing Sui, Baozhu Luo, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Entropy (Basel, Switzerland)|February 25, 2023
Change-Point Detection in a High-Dimensional Multinomial Sequence Based on Mutual InformationXinrong Xiang, Baisuo Jin, Yuehua Wu
BMC Genetics|November 25, 2020
Identifying rare variants for quantitative traits in extreme samples of population via Kullback-Leibler distanceYang Xiang, Xinrong Xiang, Yumei Li
British Journal of Pharmacology|March 30, 2022
Targeting mitochondrial proteases for therapy of acute myeloid leukaemiaXinrong Xiang, Rui Bao, Yu Wu, et al.
Cytokine|September 8, 2019
Relationship between the IL-10 (-1082 A/G) polymorphism and the risk of immune/idiopathic thrombocytopenic purpura: A meta-analysisYang Ou, Yan Yang, Xinrong Xiang, et al.
Pharmacological Research|April 1, 2022
Epigenetic changes in Mycobacterium tuberculosis and its host provide potential targets or biomarkers for drug discovery and clinical diagnosisJing Sui, Wenliang Qiao, Xinrong Xiang, et al.
Frontiers in Pharmacology|December 21, 2020
Efficacy and Safety of CAR-Modified T Cell Therapy in Patients with Relapsed or Refractory Multiple Myeloma: A Meta-Analysis of Prospective Clinical TrialsXinrong Xiang, Qiao He, Yang Ou, et al.
Cytokine|January 12, 2025
The diagnostic value and clinical correlations of bone marrow supernatant S100A8 and S100A9 in myelodysplastic neoplasmsXuefeng Li, Qing Li, Xinrong Xiang, et al.
Biomolecules|June 26, 2025
Myelodysplastic Neoplasms (MDS): Pathogenesis and Therapeutic ProspectsXuefeng Li, Chaoyu Zou, Xinrong Xiang, et al.
British Journal of Haematology|September 28, 2022
Differentiation therapy using low-dose venetoclax in a variant acute promyelocytic leukaemia carrying ZBTB16-RARAHe Li, Xinrong Xiang, Hong Ding, et al.
Journal of Medicinal Chemistry|June 21, 2024
Discovery of 5-(Piperidin-4-yl)-1,2,4-oxadiazole Derivatives as a New Class of Human Caseinolytic Protease P Agonists for the Treatment of Hepatocellular CarcinomaSong Liu, Jing Sui, Baozhu Luo, et al.
Pageof 2